CATCHLIGHT

Serial Number 88662016
606

Registration Progress

Application Filed
Oct 21, 2019
Under Examination
May 12, 2020
Approved for Publication
Mar 17, 2020
Published for Opposition
Mar 17, 2020
Registered

Trademark Image

CATCHLIGHT

Basic Information

Serial Number
88662016
Filing Date
October 21, 2019
Published for Opposition
March 17, 2020
Abandonment Date
June 13, 2022
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 13, 2022
Classes
042

Rights Holder

ADC Therapeutics SA

99
Address
Route de la Corniche, 3B
Epalinges 1066
CH

Ownership History

ADC Therapeutics SA

Original Applicant
99
Epalinges CH

ADC Therapeutics SA

Owner at Publication
99
Epalinges CH

Legal Representation

Attorney
Tracy-Gene G. Durkin

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

27 events
Date Code Type Description Documents
Oct 26, 2022 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Jun 13, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jun 13, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Oct 30, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 28, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 28, 2021 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 28, 2021 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 6, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 4, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 4, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
May 4, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Nov 14, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 12, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 12, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 12, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 12, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 17, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 17, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 26, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 7, 2020 ALIE A ASSIGNED TO LIE Loading...
Jan 28, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 28, 2020 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jan 28, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jan 28, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jan 28, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 27, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 24, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 042
Providing medical and scientific research information in the fields of pharmaceuticals and clinical trials; scientific study and research in the field of pharmaceuticals for the treatment of cancer
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Pseudo Mark
CATCH LIGHT

Classification

International Classes
042